LGT Financial Advisors’s Select Medical SEM Stock Holding History

LGT Financial Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4	Closed	-$61	–	601
2025 Q2	$61	Buy	+4	New	+$62	﹤0.01%	608

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LGT Financial Advisors's SEM Position: Q3 2025 in Review

LGT Financial Advisors sold out of Select Medical (SEM) in Q3 2025, closing a stake of 4 shares — an estimated $61 sold.

LGT Financial Advisors first reported a position in SEM in Q2 2025 and held it in 1 quarter. The position peaked at $61 in Q2 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

LGT Financial Advisors reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
LGT Financial Advisors sold 4 Select Medical shares in Q3 2025, an estimated $61.
LGT Financial Advisors first reported a position in Select Medical in Q2 2025 and held it in 1 quarter.
LGT Financial Advisors's Select Medical position peaked at $61 in Q2 2025.
268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.